gastroparesis and glp 1 drugs GLP-1 Gastroparesis: What Victims Need to Know GLP-1 Gastroparesis: Hidden Dangers Beyond

Again, we're fighting that biological imperative we've talked about

Margulies KB, Hernandez AF, Redfield MM et al (2016) Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

Brain insulin and insulin receptors in aging and sporadic Alzheimers disease

By 48 weeks, significant average weight loss was seen at all maintenance doses: With longer treatment lasting up to 68 weeks, weight loss continued, particularly at higher doses: 12mg: average weight loss of up to 28.7% of body weight This longer-term data shows that weight loss with retatrutide can continue beyond one year, rather than plateauing early, especially at higher maintenance doses